Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) PT at $120.27

HealthEquity, Inc. (NASDAQ:HQY) has been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $120.2667.

A number of brokerages have commented on HQY. Wall Street Zen cut HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Barrington Research reissued an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a research report on Thursday, December 4th. Citigroup restated an “outperform” rating on shares of HealthEquity in a report on Thursday, December 4th. Citizens Jmp lifted their price objective on shares of HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a report on Thursday, December 4th. Finally, Royal Bank Of Canada upped their target price on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, September 3rd.

Insider Transactions at HealthEquity

In other news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 17,240 shares of company stock valued at $1,640,164 over the last ninety days. 1.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Norges Bank purchased a new stake in HealthEquity in the 2nd quarter valued at about $75,072,000. Westfield Capital Management Co. LP grew its holdings in shares of HealthEquity by 124.6% in the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after acquiring an additional 701,819 shares in the last quarter. AQR Capital Management LLC increased its position in shares of HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of HealthEquity by 995.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after acquiring an additional 580,988 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in HealthEquity by 148.1% during the first quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock worth $59,203,000 after acquiring an additional 399,897 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Trading Up 1.1%

NASDAQ:HQY opened at $93.48 on Friday. HealthEquity has a 12 month low of $74.07 and a 12 month high of $116.65. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $7.99 billion, a price-to-earnings ratio of 42.88, a PEG ratio of 1.35 and a beta of 0.18. The firm has a fifty day simple moving average of $97.28 and a two-hundred day simple moving average of $95.80.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The company had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter in the prior year, the firm earned $0.78 EPS. The business’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Analysts expect that HealthEquity will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.